Prazer Therapeutics is Drug Discovery in South Korea that focus on inflammatory diseases business. Founded in 2019. They cover business area such as operator, biotechnology company, novel therapeutic, refractory disease, neurodegenerative disease, refractory inflammatory disease, next-generation protein degradation technology, researcher, advancement, novel drug, area, unmet medical need.
2019
( 5 years old in 2024 )
Inflammatory Diseases
-
117-3 Hoegi-ro Dongdaemun-gu
Seoul
South Korea
Private
operatorbiotechnology companynovel therapeuticrefractory diseaseneurodegenerative diseaserefractory inflammatory diseasenext-generation protein degradation technologyresearcheradvancementnovel drugareaunmet medical need
* We use standard office opening hours in near Prazer Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Prazer Therapeutics is Drug Discovery business from South Korea that founded in 2019 (5 years old in 2024), Prazer Therapeutics business is focusing on Inflammatory Diseases.
Prazer Therapeutics headquarter office and corporate office address is located in 117-3 Hoegi-ro Dongdaemun-gu Seoul South Korea.
Prazer Therapeutics was founded in South Korea.
In 2024, Prazer Therapeutics is currently focus on inflammatory diseases sector.
Above is snippet of Google Trends for "inflammatory diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Prazer Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
